Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Sanofi

Shanghai Composite Index Fell 0.4% on Wednesday

Shenzhen Component Index closed down 0.31%

Caixin Global

Novavax Cut Its Outlook Despite Beating Third-Quarter Forecasts. Is It A Sell In December 2024?

Things were looking up for Novavax stock after the FDA resolved a clinical hold. But the company trimmed its outlook. Is NVAX stock a sell in December 2024?

Investors Business Daily

3 Gene-Editing Stocks to Buy for Future Health Advances

With ever-expanding operations and rapid technological innovations, the gene-editing industry looks poised for solid long-term growth. Thus, investors could consider solid stocks Eli Lilly (LLY), Sanofi (SNY), and Vertex Pharmaceuticals (VRTX). Continue reading.

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

3 Blue-Chip Stocks With Strong Buy Ratings

Blue-chip stocks offer stability and consistent growth irrespective of market conditions. Thus, blue chip names Lockheed Martin (LMT), Regeneron Pharmaceuticals (REGN), and Cigna Group (CI) could be prudent additions to your portfolios. These stocks are Strong Buy-rated in our proprietary POWR Ratings system. Read on.

StockNews.com

AnaptysBio Surges After Sanofi Takes A Stake In $100 Million Offering

AnaptysBio stock zoomed higher Wednesday after announcing a $100 million offering that includes participation from pharma giant Sanofi.

Investors Business Daily

From Ice Baths To Osteopaths: Unproven Therapies At The Olympics

The Paris Olympics have been a showcase not only for athletic prowess but also for therapies such as ice baths and osteopathy which have little scientifically proven medical value, according to experts.

International Business Times

3 Biotech Stocks With Revolutionary Pipelines to Buy Today

The biotech industry is experiencing rapid growth owing to new drug innovations and advancements in healthcare. To capitalize on the industry's expansion, it could be wise to invest in solid biotech stocks, Vertex Pharmaceuticals (VRTX), Regeneron Pharmaceuticals (REGN), and Gilead Sciences (GILD), which have revolutionary pipelines. Read on….

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

Are these the most corporate Olympics ever?

It’s rather exceptional that a G7 Olympic host gets the support of so many of its largest companies.

Fortune

AstraZeneca Says It Has A 'Powerful' — And Differentiated — Approach To Obesity Treatment

AstraZeneca stock skidded Thursday despite strong quarterly sales as an FDA panel met to discuss its lung cancer treatment.

Investors Business Daily

What The Quest For New Cholesterol Treatments Means For Novartis, Merck — And Patients

A renaissance is stirring in cholesterol treatment, and it could drive Merck, Novartis and other stocks higher, while delivering new choices for millions of patients.

Investors Business Daily

Can I take antihistamines everyday? More than the recommended dose? What if I’m pregnant? Here’s what the research says

Allergies happen when your immune system overreacts to a normally harmless substance like dust or pollen. Hay fever, hives and anaphylaxis are all types of allergic reactions.

The Conversation

The secrets of success with Paul Hudson, CEO of Sanofi

Today we meet with British CEO Paul Hudson to find out how he plans to build the Sanofi of tomorrow.

Fortune

Why It's A New Day For COPD Patients — And Regeneron, Sanofi, Verona Stocks

There hasn't been a new COPD treatment in years. But Regeneron stock analysts are closely watching a pair of key FDA decisions.

Investors Business Daily

Why Big-Name Biotech Regeneron Pharma Just Joined The 1,000-Club

Regeneron stock joined the 1,000-club this month as enthusiasm grows for its blockbuster drug, Dupixent, in COPD treatment.

Investors Business Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Moderna Says Combination Flu And Covid Vaccine Beat Out Rivals From Sanofi, GSK

Moderna said Monday its Covid/flu vaccine topped rivals from GSK and Sanofi, and its own Spikevax shot. But Moderna stock fell.

Fortune

Usher and Apple CEO Tim Cook had a meeting. Now the Super Bowl performer is taking his ideas to Capitol Hill

Usher will join French pharma giant Sanofi in Washington, D.C., to discuss the importance of early screening for type 1 diabetes.

Fortune

Sanofi’s CEO thinks OpenAI offers 'insane' potential for the pharmaceutical industry

Sanofi CEO Paul Hudson thinks AI offers 'insane' potential for the pharmaceutical industry, which can spend up to $4 billion developing a drug.

International Business Times

Sanofi Allies With OpenAI, Formation Bio For AI Use In Drug Development

French pharmaceutical company Sanofi announced Tuesday a partnership with ChatGPT-founder OpenAI and US biotech firm Formation Bio to accelerate the use of artificial intelligence in developing drugs.

Get all your
news in one place.

100’s of premium titles.
One news app.

The Guardian - UK

‘The issue is when to pull the trigger’: how prepared are we for human bird flu?

The H5N1 virus has been devastating bird populations, and is now infecting mammals too. Is human-to-human transmission next? And are we ready for another pandemic?

Kiplinger

Stock Market Today: Stocks End Mixed on the Day, Higher on the Week

The latest consumer sentiment data showed inflation concerns are on the rise.

Investors Business Daily

Biotech Rockets 125% On Sanofi Covid Vaccine Agreement

Novavax will receive as much as $1.2 billion as part of a Covid vaccine licensing deal with Sanofi.

Axios

Novavax strikes $1.2 billion deal with Sanofi in major turnaround

It's a major turnaround for a drug company that warned last year about its ability to stay in business.

International Business Times

French, US Drug Firms Team Up For Covid-flu Shot

French pharmaceutical giant Sanofi and struggling US rival Novavax announced Friday an alliance to sell a Covid vaccine and develop another that combines with a flu shot.

Al Jazeera

What is behind the insulin shortage in the US?

Pharma companies are slashing insulin production in favour of more lucrative weight-loss drugs.

Investors Business Daily

AstraZeneca Flirts With A Breakout After Cancer Drug Sales Shine; Sanofi, Bristol Stocks Diverge

AstraZeneca stock bolted higher Thursday — and is now within striking distance of a breakout — after its cancer drugs propelled a sales beat.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.